Compound 1 of the series was found to be potent EGFR inhibitor with an IC50 value of 14.05 μmol/ml, it also displayed potent anticancer activity against HeLa cancer cell line with an IC50 value of 0.42 μM. The gene discussed is EGFR; the disease is cancer.